Graham Mills

Graham joined Abingworth’s London office in January 2022 working with the transatlantic team in evaluating new investment opportunities and supporting existing portfolio companies in a therapeutic area-agnostic approach.

Previously, Graham was Founder & Managing Director at healthcare-focused tech startup techspert.io, where he built significant experience in scaling early-stage ventures and navigating the challenges through development. Before & alongside this, Graham worked actively in the investment teams of JJDC and Seroba Life Sciences, developing broad investment theses through new opportunity evaluation and detailed therapeutic landscape analyses.

Graham holds a Ph.D. in Medical Biology from the University of Cambridge, an MRes in Translational Cancer Medicine from King’s College London, a BA in Genetics from Trinity College Dublin, and an MBA from the Quantic School of Business & Technology.